Predictors of left ventricular ejection fraction recovery after guideline-directed medical therapy in patients with newly diagnosed dilated cardiomyopathy and baseline LVEF ≤35%
Frontiers in Cardiovascular Medicine · 12.06.2026 · 13
DOI: 10.3389/fcvm.2026.1767079 ↗Kurz gefasst
Leitlinie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 12.06.2026. Verfasst von Yang Pu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with newly diagnosed dilated cardiomyopathy (DCM) and a baseline left ventricular ejection fraction (LVEF) ≤35% generally have a poor prognosis. Early identification of patients who are unlikely to recover LVEF after guideline-directed medical therapy (GDMT) is clinically important for risk stratification, closer follow-up, repeated LVEF assessment, and timely reassessment of guideline-based device therapy eligibility.
Methods
This retrospective cohort study enrolled 198 patients with newly diagnosed dilated cardiomyopathy (DCM) and baseline left ventricular ejection fraction (LVEF) ≤35%, all of whom received standardized guideline-directed medical therapy (GDMT) for 3∼6 months. Baseline and follow-up echocardiographic, electrocardiographic, clinical, and laboratory data were collected. The primary outcome was recovery of LVEF to >35% after treatment. The secondary outcome was the first occurrence of cardiovascular death or rehospitalization for heart failure during follow-up. Multivariable Firth Logistic regression was used to identify independent predictors and to develop a prediction model, which was internally validated using the area under the receiver operating characteristic curve (ROC AUC), the Hosmer–Lemeshow goodness-of-fit test, and decision curve analysis. Cox proportional hazards regression was used to evaluate predictors of long-term prognosis, and time-dependent ROC analysis was performed.
Results
Multivariable Firth logistic regression showed that absence of left bundle branch block (LBBB) and higher apolipoprotein A1 (ApoA1) levels were independently associated with LVEF recovery to >35%. The presence of LBBB was strongly associated with a lower likelihood of LVEF recovery (OR = 0.02, 95% CI 0.00–0.13, P < 0.001), whereas higher ApoA1 levels were associated with a greater likelihood of recovery (OR = 1.40 per 10-unit increase, 95% CI 1.06–1.86, P = 0.019). A model integrating LBBB, ApoA1, and age demonstrated good discrimination, with ROC AUCs of 0.93 in the training set and 0.88 in the validation set, good calibration, and positive net benefit on decision curve analysis.
Conclusions
The model may help with early risk stratification, closer surveillance, repeated LVEF assessment, and timely reassessment of guideline-based ICD eligibility. However, external validation is required before routine clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
- Cardiovascular Department, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China.
- Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.
Zitieren
APA
Pu, Y., Liu, Y., Zhang, N., Yang, Y., Zhao, Y., Zhu, D., Li, X., Song, Y., Fu, J., Shen, S., & Chen, L. (2026). Predictors of left ventricular ejection fraction recovery after guideline-directed medical therapy in patients with newly diagnosed dilated cardiomyopathy and baseline LVEF ≤35%. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1767079
Vancouver
Pu Y, Liu Y, Zhang N, Yang Y, Zhao Y, Zhu D, et al. Predictors of left ventricular ejection fraction recovery after guideline-directed medical therapy in patients with newly diagnosed dilated cardiomyopathy and baseline LVEF ≤35%. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1767079
BibTeX
@article{Pu2026,
author = {Pu, Yang and Liu, Yaowu and Zhang, Ningyue and Yang, Yuanqi and Zhao, Yingming and Zhu, Didi and Li, Xudong and Song, Yunfeng and Fu, Jinling and Shen, Shaojie and Chen, Long},
title = {Predictors of left ventricular ejection fraction recovery after guideline-directed medical therapy in patients with newly diagnosed dilated cardiomyopathy and baseline LVEF ≤35%},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1767079}
}
EUVIMED